Diabetic Eye Screening Programme

View buyer

Estimated value

£11.6m

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

18 May 2018

Deadline 20 Jun 2018

Description

The aim of the service is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, and population-based screening programmes that: - identify the eligible population and ensure effective delivery with maximum coverage; - are safe, effective, of a high quality, externally and independently monitored, and quality assured; - lead to earlier detection, appropriate referral, effective treatment and improved outcomes; - are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuing Medical Education (CME), Continuous Professional Development (CPD), and Quality Assurance (QA) schemes; and - have audit embedded in the service. The contract term will be for an initial period of 3 years with the option to extend the contract by a further 24 Months at the discretion of the Commissioner and subject to satisfactory contractual and financial performance

Scope

Reference
MT212030
Total value
£11,589,593 excluding VAT
Commercial tool
Standalone contract
Contract dates
31 Mar 2019 to 31 Mar 2024
CPV classifications
85100000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
20 Jun 2018, 11:00 pm